Form 4 for OGN Organon & Co.
Accepted 2023-03-02 00:00:00 ET · period of report 2023-02-28 · accession 0001209191-23-014842 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-02 | 2023-02-28 | OGN | Milligan Sandra | Head of Research, Development | M - OptEx | — | +7,976 | 23.2K | +52% | — |
| D | 2023-03-02 | 2023-02-28 | OGN | Milligan Sandra | Head of Research, Development | F - Tax | $25.09 | -2,346 | 20.9K | -10% | -$58.9K |
| D | 2023-03-02 | 2023-02-28 | OGN | Milligan Sandra | Head of Research, Development | M - OptEx | $0.00 | -7,976 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-28 | M | A | 7,976 | — | 23,207 | D | — | — | (F1) Each Restricted Stock Unit converts into one share of Organon & Co. common stock. |
| 2 | Common | Common Stock | 2023-02-28 | F | D | 2,346 | $25.09 | 20,861 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2023-02-28 | M | D | 7,976 | $0.00 | 0 | D | — · 2022-12-31 to 2022-12-31 | 7,976 Common Stock | (F2) As originally reported on the Form 4, dated June 4, 2021, these Restricted Stock Units vested on December 31, 2022. These Restricted Stock Units were subsequently distributed to the Reporting Person on February 28, 2023. (F3) The amount of Restricted Stock Units has been slightly adjusted from the Reporting Person's Form 4, dated June 4, 2021, based on the finalization of certain calculations. (F1) Each Restricted Stock Unit converts into one share of Organon & Co. common stock. |